stars 1 stars 2 stars 3

We are pioneering the next-generation biochip for research, diagnostics, and personalized medicine. Our biochip platform offers ultra-high feature density, modularity, and adaptability to integrate and enhance sequencing, transcriptomics, and proteomics applications. To realize this vision, SPRIND - Germany's Federal Agency for Disruptive Innovation funds Nanogami as one of six projects for the next five years.

Employees 13 (13 on RocketReach)
Founded 2022
Industry Biotechnology Research

Nanogami Questions

Katarina Irić is the VP, Sequencing and Omics (Product and Commercial Strategy) of Nanogami.

13 people are employed at Nanogami.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users